Literature DB >> 26436010

Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review.

Maheshwar Lakkireddy1, Vijaykrishna Chilakamarri2, Prajnya Ranganath3, Abhishek Jagdishchander Arora4, Maria Celestina Vanaja5.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformation of the great toes and disabling heterotopic ossification in specific anatomic locations with a world wide prevalence of 1 in 2 million population. Nearly 90% of patients with FOP are misdiagnosed and mismanaged. We present a case of a four-year-old boy brought by his parents with the complaints of stiffness of right shoulder, neck and multiple swellings over the upper back noted over the past 4 months. On examination bilateral symmetrical hallux valgus with microdactyly of great toes and multiple bony hard swellings on both the scapulae were noted. Skeletal survey revealed all the classical features of FOP. Mutation of the ACVR1gene on genetic analysis confirmed the diagnosis of FOP. Invasive surgical procedures including biopsy and manipulations for stiff joints were avoided as they strikingly end up in rapid progression of FOP. Congenital hallux valgus with short great toe in a child should be considered as an early diagnostic tool for FOP even before the onset of mass lesions. Genetic analysis for mutation of ACVR1gene is confirmatory. Prevention of injury, medical management of acute painful flare-ups and rehabilitation are the mainstay of treatment.

Entities:  

Keywords:  ACVR1 gene; Congenital hallux valgus; Heterotopic ossification; Iatrogenic Injury; Myositis ossificans progressiva

Year:  2015        PMID: 26436010      PMCID: PMC4576603          DOI: 10.7860/JCDR/2015/15160.6393

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

2.  Myositis ossificans progressiva (Munchmeyer's disease). Brief review with report of two cases treated with corticosteroids and observed for 16 years.

Authors:  R S Illingworth
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

3.  Fibrodysplasia (myositis) ossificans progressiva: clinicopathological features and natural history.

Authors:  R Smith; N A Athanasou; S E Vipond
Journal:  QJM       Date:  1996-06

4.  Evaluation of 20 years experience of fibrodysplasia ossificans progressiva in Iran: lessons for early diagnosis and prevention.

Authors:  Seyed Reza Raees-Karami; Hanieh Jafarieh; Vahid Ziyayi; Reza Shekarriz Foumani; Yahya Aghighi
Journal:  Clin Rheumatol       Date:  2012-04-20       Impact factor: 2.980

5.  Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Sharon Kantanie; David M Rocke; Frederick S Kaplan
Journal:  Pediatrics       Date:  2005-10-17       Impact factor: 7.124

6.  Early diagnosis of fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Meiqi Xu; David L Glaser; Felicity Collins; Michael Connor; Joseph Kitterman; David Sillence; Elaine Zackai; Vardit Ravitsky; Michael Zasloff; Arupa Ganguly; Eileen M Shore
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

7.  The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

Authors:  F S Kaplan; J A Tabas; F H Gannon; G Finkel; G V Hahn; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

Review 8.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 9.  Fibrodysplasia ossificans progressiva: clinical and genetic aspects.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Orphanet J Rare Dis       Date:  2011-12-01       Impact factor: 4.123

  9 in total
  2 in total

1.  Longitudinal Evaluation of Pain, Flare-Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry.

Authors:  Ke Peng; Kin Cheung; Arielle Lee; Christine Sieberg; David Borsook; Jaymin Upadhyay
Journal:  JBMR Plus       Date:  2019-03-01

2.  Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report.

Authors:  Shengjie Tian; Jianhua Zhu; Yaogang Lu
Journal:  BMC Med Genet       Date:  2018-02-27       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.